Insulin glulisine - Apidra; [LysB3, GluB29] insulin; insulin (human), 3B-l-lysine, 29B-l-glutamic acid-, recombinant -- Product Record

Insulin glulisine, rDNA

    Nomenclature:
      Insulin glulisine, rDNA [BIO]
      Apidra [TR]
      insulin glulisine [USAN; INN]
      [3B-B-lysine, 29 B-L-glutamic acid]insulin (human)

      [CAS]
      insulin (human), 3B-L-lysine,29B-L-glutamic acid-
      [CAS]
      207748-29-6 [CAS RN]
      HMR 1964 [SY]
      HMR-1964 [SY]
      [LysB3, GluB29] insulin [SY]
      NDC 0088-2500-33 [NDC]

    molecular weight (kDa) = 5.8 [51 a.a. polypeptide]

    FDA Class:  Drug NDA

    Year of approval (FDA) = 2004